Contagion® is the go-to news resource for practitioners and specialists working in infectious disease.
Get the content you want anytime you want.
REGISTER NOW | SIGN IN
Like Us On Facebook
Follow Us On Twitter
Check us out on LinkedIn
Subscribe us on YouTube
CONFERENCES
OUTBREAK MONITOR
PUBLICATION
SEARCH
DISEASE-SPECIFIC TOPICS
The Top Infectious Disease News Delivered Weekly
SIGN UP NOW

Latest News From Contagion® Live

Latest News

The ID Pipeline: FDA Activity From the Week of December 8, 2019
The ID Pipeline: FDA Activity From the Week of December 8, 2019
Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 8, 2019.
 
Read more >>
Recalls That Should Be on Your Radar—Week of December 8, 2019
Recalls That Should Be on Your Radar—Week of December 8, 2019
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
Read more >>
FDA Clears First Disposable Duodenoscope
FDA Clears First Disposable Duodenoscope
The US Food and Drug Administration today cleared for marketing the first fully disposable duodenoscope.
Read more >>
Top Infectious Disease News of the Week—December 8, 2019
Top Infectious Disease News of the Week—December 8, 2019
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Read more >>
Keith Kaye, MD, MPH, on the Approval of Imipenem/Cilastatin + Relebactam
Keith Kaye, MD, MPH, on the Approval of Imipenem/Cilastatin + Relebactam
imipenem/cilastatin plus relebactam was approved for the treatment of cUTIs and cIAIs in adult patients with limited or no available treatment options.
Read more >>
Yoav Golan, MD, on the Recent Approval of Ceftolozane/Tazobactam for HABP/VABP
Yoav Golan, MD, on the Recent Approval of Ceftolozane/Tazobactam for HABP/VABP
This approval allows ceftolozane/tazobactam to be used to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP).
Read more >>
New Diagnostic Tools in the Diagnosis of Bone and Joint Infections
New Diagnostic Tools in the Diagnosis of Bone and Joint Infections
Improving diagnostics needs a culture change.
Read more >>
The Year Ends With a Big Step in PrEP and PEP
The Year Ends With a Big Step in PrEP and PEP
Something novel in infectious diseases practice has occurred and, like many big changes, it is not without controversy. 
Read more >>
Next Page >>
FEATURED
Working Toward a Cure for HIV: Where Are We?
Working Toward a Cure for HIV: Where Are We?
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?
RELATED SITES
MJH Associates
 
ContagionLive
About Contagion®
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
Like Us On Facebook
Follow Us On Twitter
Check us out on LinkedIn
Subscribe us on YouTube
 
 
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
 
 
About Us | Contact Us | Press Release | Privacy Policy | Terms & Conditions
Copyright© 2006-2019 Intellisphere, LLC. All Rights Reserved.